Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Clinical trial NCT06937905 · RECRUITING
Trial details
- NCT number
- NCT06937905
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-06
- Primary completion
- 2029-02-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.